{
    "organizations": [],
    "uuid": "64eef41790380c9c5c04d9760e1a3480c1c2848c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-alexion-to-acquire-wilson-therapeu/brief-alexion-to-acquire-wilson-therapeutics-idUSASC09VHW",
    "ord_in_thread": 0,
    "title": "BRIEF-Alexion To Acquire Wilson Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11, 2018 / 6:07 AM / Updated 27 minutes ago BRIEF-Alexion To Acquire Wilson Therapeutics Reuters Staff \nApril 11 (Reuters) - Alexion Pharmaceuticals Inc: * ALEXION TO ACQUIRE WILSON THERAPEUTICS \n* SAYS ALEXION WILL ACQUIRE WILSON THERAPEUTICS THROUGH A TENDER OFFER \n* SAYS TOTAL EQUITY VALUE OF TRANSACTION AMOUNTS TO SEK 7,100 MILLION, OR APPROXIMATELY $855 MILLION \n* SAYS ALEXION INTENDS TO FINANCE ACQUISITION THROUGH CASH ON HAND. Source text for Eikon: Further company coverage:",
    "published": "2018-04-11T09:03:00.000+03:00",
    "crawled": "2018-04-11T09:23:11.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "acquire",
        "wilson",
        "therapeutic",
        "reuters",
        "staff",
        "april",
        "reuters",
        "alexion",
        "pharmaceutical",
        "inc",
        "alexion",
        "acquire",
        "wilson",
        "therapeutic",
        "say",
        "alexion",
        "acquire",
        "wilson",
        "therapeutic",
        "tender",
        "offer",
        "say",
        "total",
        "equity",
        "value",
        "transaction",
        "amount",
        "sek",
        "million",
        "approximately",
        "million",
        "say",
        "alexion",
        "intends",
        "finance",
        "acquisition",
        "cash",
        "hand",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}